2023 Q4 Form 10-Q Financial Statement

#000010359523000016 Filed on December 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $536.4M $553.8M
YoY Change 3.21% 4.99%
Cost Of Revenue $383.4M $392.7M
YoY Change 3.51% 3.56%
Gross Profit $152.9M $161.1M
YoY Change 2.45% 8.64%
Gross Profit Margin 28.52% 29.09%
Selling, General & Admin $130.3M $132.5M
YoY Change 3.77% 8.54%
% of Gross Profit 85.19% 82.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.967M $8.800M
YoY Change 0.19% 1.79%
% of Gross Profit 5.86% 5.46%
Operating Expenses $138.8M $140.9M
YoY Change 3.5% 8.16%
Operating Profit $14.15M $20.20M
YoY Change -6.76% 12.15%
Interest Expense $1.064M $2.500M
YoY Change -2.12% 1101.92%
% of Operating Profit 7.52% 12.38%
Other Income/Expense, Net
YoY Change
Pretax Income $16.91M $22.70M
YoY Change 5.32% 24.59%
Income Tax $5.326M $7.400M
% Of Pretax Income 31.49% 32.6%
Net Earnings $11.59M $14.70M
YoY Change 4.55% 16.64%
Net Earnings / Revenue 2.16% 2.65%
Basic Earnings Per Share
Diluted Earnings Per Share $0.60 $1.02
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $134.8M $140.9M
YoY Change 13.02% 4.5%
Cash & Equivalents $134.8M $140.9M
Short-Term Investments
Other Short-Term Assets $17.68M $17.31M
YoY Change -2.44% -0.76%
Inventory $47.49M $44.52M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $249.5M $246.7M
YoY Change 22.7% 3.67%
LONG-TERM ASSETS
Property, Plant & Equipment $281.6M $277.3M
YoY Change 5.14% -50.36%
Goodwill $24.19M $24.19M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $14.97M $13.16M
YoY Change 77.39% 83.68%
Other Assets $40.41M $36.40M
YoY Change 4.55% 5.99%
Total Long-Term Assets $727.2M $721.0M
YoY Change -2.78% 5.03%
TOTAL ASSETS
Total Short-Term Assets $249.5M $246.7M
Total Long-Term Assets $727.2M $721.0M
Total Assets $976.7M $967.7M
YoY Change 2.67% 4.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $116.1M $108.4M
YoY Change 44.1% 40.71%
Accrued Expenses $49.37M $50.20M
YoY Change 4.83% 5.52%
Deferred Revenue
YoY Change
Short-Term Debt $754.0K $700.0K
YoY Change -36.48% -38.27%
Long-Term Debt Due $9.370M $9.370M
YoY Change 5.34% 25.5%
Total Short-Term Liabilities $183.2M $179.0M
YoY Change 6.35% 13.15%
LONG-TERM LIABILITIES
Long-Term Debt $70.04M $72.43M
YoY Change -3.79% -19.29%
Other Long-Term Liabilities $282.3M $283.8M
YoY Change -5.89% -6.78%
Total Long-Term Liabilities $70.04M $72.43M
YoY Change -3.79% -81.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.2M $179.0M
Total Long-Term Liabilities $70.04M $72.43M
Total Liabilities $253.2M $251.4M
YoY Change 3.34% -54.48%
SHAREHOLDERS EQUITY
Retained Earnings $351.7M $343.5M
YoY Change 11.73% 11.9%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $419.2M $410.2M
YoY Change
Total Liabilities & Shareholders Equity $976.7M $967.7M
YoY Change 2.67% 4.68%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $11.59M $14.70M
YoY Change 4.55% 16.64%
Depreciation, Depletion And Amortization $8.967M $8.800M
YoY Change 0.19% 1.79%
Cash From Operating Activities $18.38M $36.30M
YoY Change -16.53% 30.0%
INVESTING ACTIVITIES
Capital Expenditures $13.77M $10.70M
YoY Change 40.35% -266.25%
Acquisitions
YoY Change
Other Investing Activities -$3.913M -$3.500M
YoY Change -87.84% 193.87%
Cash From Investing Activities -$17.69M -$14.20M
YoY Change -57.88% 86.18%
FINANCING ACTIVITIES
Cash Dividend Paid $3.350M
YoY Change 3.01%
Common Stock Issuance & Retirement, Net $782.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$6.830M -5.700M
YoY Change -255.76% 5.97%
NET CHANGE
Cash From Operating Activities $18.38M 36.30M
Cash From Investing Activities -$17.69M -14.20M
Cash From Financing Activities -$6.830M -5.700M
Net Change In Cash -$6.137M 16.40M
YoY Change -60.62% 9.94%
FREE CASH FLOW
Cash From Operating Activities $18.38M $36.30M
Capital Expenditures $13.77M $10.70M
Free Cash Flow $4.606M $25.60M
YoY Change -62.26% -25.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Interest Expense
InterestExpense
1064000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
1087000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
782000 usd
CY2023Q4 us-gaap Stock Granted During Period Value Sharebased Compensation Forfeited
StockGrantedDuringPeriodValueSharebasedCompensationForfeited
28000 usd
CY2023Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
952000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
419245000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
372109000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11081000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1199000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2669000 usd
CY2022Q4 us-gaap Dividends
Dividends
3252000 usd
CY2022Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
608000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
383215000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
11585000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11081000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8967000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8950000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
924000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
608000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-207000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
103000 usd
CY2023Q4 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
466000 usd
CY2022Q4 us-gaap Inventory Lifo Reserve Effect On Income Net
InventoryLIFOReserveEffectOnIncomeNet
538000 usd
CY2023Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
39000 usd
CY2022Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
17000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3443000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4893000 usd
CY2023Q4 vlgea Change In Patronage Dividend Receivable
ChangeInPatronageDividendReceivable
4849000 usd
CY2022Q4 vlgea Change In Patronage Dividend Receivable
ChangeInPatronageDividendReceivable
4745000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
4216000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
3760000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3954000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3389000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-1420000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-697000 usd
CY2023Q4 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-2602000 usd
CY2022Q4 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
4492000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-827000 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
550000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18379000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22019000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13773000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9813000 usd
CY2023Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39000 usd
CY2022Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000 usd
CY2023Q4 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-2139000 usd
CY2022Q4 us-gaap Proceeds From Payments For Long Term Loans For Related Parties
ProceedsFromPaymentsForLongTermLoansForRelatedParties
-59767000 usd
CY2023Q4 us-gaap Proceeds From Sale Maturity And Collection Of Longterm Investments
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
0 usd
CY2022Q4 us-gaap Proceeds From Sale Maturity And Collection Of Longterm Investments
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
28850000 usd
CY2023Q4 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
1813000 usd
CY2022Q4 us-gaap Payments To Acquire Limited Partnership Interests
PaymentsToAcquireLimitedPartnershipInterests
1276000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17686000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41989000 usd
CY2023Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000 usd
CY2023Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2698000 usd
CY2022Q4 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2352000 usd
CY2023Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
11000 usd
CY2023Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
3350000 usd
CY2022Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
3252000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
782000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6830000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4385000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6137000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15585000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140910000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134832000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
134773000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
119247000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
1064000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
1087000 usd
CY2023Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
8135000 usd
CY2022Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
380000 usd
CY2023Q4 us-gaap Notes Issued1
NotesIssued1
38000 usd
CY2022Q4 us-gaap Notes Issued1
NotesIssued1
0 usd
CY2023Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5086000 usd
CY2022Q4 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5427000 usd
CY2023Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
908000 usd
CY2022Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
536354000 usd
CY2023Q4 vlgea Percentageof Total Sales
PercentageofTotalSales
1.000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
519689000 usd
CY2022Q4 vlgea Percentageof Total Sales
PercentageofTotalSales
1.000
CY2023Q4 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.63
CY2023Q3 us-gaap Percentage Of Lifo Inventory
PercentageOfLIFOInventory
0.64
CY2023Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
21704000 usd
CY2023Q3 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
21238000 usd
CY2023Q4 vlgea Numberof Classesof Common Stock
NumberofClassesofCommonStock
2 class
CY2023Q4 vlgea Dividends Common Stock Cash Percent Class Ais Entitled Greaterthan Class B
DividendsCommonStockCashPercentClassAisEntitledGreaterthanClassB
0.54
CY2023Q4 vlgea Dividends Common Stock Cash Percent Class Ais Entitled Greaterthan Class B
DividendsCommonStockCashPercentClassAisEntitledGreaterthanClassB
0.54
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
11585000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
11081000 usd
CY2023Q4 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
440000 usd
CY2022Q4 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
304000 usd
CY2023Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11145000 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10777000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
79409000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
81796000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9370000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9370000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
70039000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72426000 usd
CY2020Q3 vlgea Debt Instrument Collateral Number Of Stores
DebtInstrumentCollateralNumberOfStores
3 store
CY2017Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
4835000 usd
CY2017Q4 vlgea Interest On Unrelated Party Note Receivable Percentage
InterestOnUnrelatedPartyNoteReceivablePercentage
0.01403
CY2017Q4 vlgea Third Party Contributionto Investment Fund
ThirdPartyContributiontoInvestmentFund
2375000 usd
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
6563000 usd
CY2017Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.01000
CY2023Q4 us-gaap Derivative Number Of Instruments Held
DerivativeNumberOfInstrumentsHeld
5 swap

Files In Submission

Name View Source Status
0000103595-23-000016-index-headers.html Edgar Link pending
0000103595-23-000016-index.html Edgar Link pending
0000103595-23-000016.txt Edgar Link pending
0000103595-23-000016-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vlgea-20231028.htm Edgar Link pending
vlgea-20231028.xsd Edgar Link pending
vlgea2023102810-qexhibit991.htm Edgar Link pending
vlgea20231028ex-311.htm Edgar Link pending
vlgea20231028ex-312.htm Edgar Link pending
vlgea20231028ex-321.htm Edgar Link pending
vlgea20231028ex-322.htm Edgar Link pending
vlgea-20231028_cal.xml Edgar Link unprocessable
vlgea-20231028_def.xml Edgar Link unprocessable
vlgea-20231028_pre.xml Edgar Link unprocessable
vlgea-20231028_lab.xml Edgar Link unprocessable
vlgea-20231028_htm.xml Edgar Link completed